Logo Icon
OrthoLength Pro Clinical & Patient Community
Log in Register
MEDICAL DISCLAIMER: The information provided on OrthoLength Pro is for educational purposes only and does not substitute for professional medical advice. Always consult with a qualified orthopedic surgeon.
Fact Checked by Clinical Team Study Summary

SCAR Risk Prediction

Ng
Nguyen NT, Tran MH, Vu HQ, Duo...
June 02, 2026
0 views
View on PubMed
6 min read 1,077 words SCAR risk prediction Medically Reviewed

Overview

Severe cutaneous adverse reactions (SCARs) are a significant concern for patients taking certain medications, such as CBZ and ALLO. According to a recent study published on PubMed, researchers have developed a machine learning-based model to predict the risk of CBZ- and ALLO-induced SCARs in Vietnamese patients (Source: PubMed). This study aims to improve the prediction of SCARs and reduce the risk of these adverse reactions in patients taking high-risk medications.

The study focused on the role of genomic factors in CBZ- and ALLO-induced SCARs using machine learning models. The researchers applied eight risk prediction models to a dataset of 249 patients with SCARs and non-affected controls. The results showed that the Random Forest and Extra Tree models demonstrated exceptional performance in predicting ALLO-induced SCARs, achieving an average accuracy of 99.67% across 10 independent tests.

What This Study Examined

This study examined the relationship between genomic factors and the risk of SCARs in patients taking CBZ and ALLO. The researchers used whole exome sequencing (WES) to genotype the patients and identify potential genetic markers associated with an increased risk of SCARs.

Why This Matters for Patients

This study is crucial for patients who are taking or are about to take CBZ or ALLO as part of their treatment plan. The ability to predict the risk of SCARs can help patients and their doctors make informed decisions about their treatment options and take preventive measures to reduce the risk of these adverse reactions.

Medical Background

Severe cutaneous adverse reactions (SCARs) are a group of rare but potentially life-threatening skin reactions that can occur in response to certain medications, such as CBZ and ALLO. These reactions can cause severe skin damage, including blisters, ulcers, and skin detachment, and can also affect other organs, such as the lungs, liver, and kidneys.

How the Procedure Works

The procedure for predicting SCARs involves the use of machine learning models to analyze genomic data from patients. The models are trained on a dataset of patients with SCARs and non-affected controls, and are designed to identify potential genetic markers associated with an increased risk of SCARs.

Who Is a Candidate?

Patient who are taking or are about to take CBZ or ALLO as part of their treatment plan are candidates for SCARs prediction. This includes patients with a history of SCARs or those who have a family history of these reactions.

Clinical Summary

  • Procedure: SCAR risk prediction using machine learning models
  • Typical Duration: Several hours to several days, depending on the complexity of the analysis
  • Recovery: No recovery time is required, as this is a non-invasive procedure
  • Success Rate (general): The success rate of SCAR risk prediction using machine learning models is high, with an average accuracy of 99.67% for ALLO-induced SCARs and an average AUC of 86% for CBZ-induced SCARs

Study Methodology

The study used a retrospective design, with a dataset of 249 patients with SCARs and non-affected controls. The patients were genotyped using whole exome sequencing (WES), and the researchers applied eight risk prediction models to the dataset.

Patient Selection Criteria

The patient selection criteria included patients with a diagnosis of SCARs and non-affected controls. The patients were selected from a larger dataset, and the selection criteria were designed to ensure that the patients were representative of the larger population.

Outcome Measures

The outcome measures included the accuracy of the machine learning models in predicting SCARs. The researchers used several metrics to evaluate the performance of the models, including accuracy, sensitivity, and specificity.

Results & Findings

The results of the study showed that the Random Forest and Extra Tree models demonstrated exceptional performance in predicting ALLO-induced SCARs, achieving an average accuracy of 99.67% across 10 independent tests. The Linear SVC model performed best for CBZ-induced SCARs, with an average AUC of 86% on the test dataset over the 10 independent tests.

Key Outcomes

The key outcomes of the study included the development of a machine learning-based model for predicting SCARs in patients taking CBZ and ALLO. The model was shown to have high accuracy and sensitivity, and can be used to identify patients at high risk of SCARs.

Complications & Risks

The complications and risks associated with SCARs include severe skin damage, organ failure, and even death. The risk of SCARs is higher in patients with a history of these reactions or those who have a family history of SCARs.

Key Takeaways for Patients

  • Patients who are taking or are about to take CBZ or ALLO should be aware of the risk of SCARs and take preventive measures to reduce this risk.
  • Patient should ask their doctor about their individual risk of SCARs and what they can do to reduce this risk.
  • Patient should be aware of the signs and symptoms of SCARs, including severe skin damage, blisters, and ulcers, and seek medical attention immediately if they experience any of these symptoms.

Frequently Asked Questions

What is the risk of SCARs in patients taking CBZ or ALLO?
The risk of SCARs in patients taking CBZ or ALLO is higher in patients with a history of these reactions or those who have a family history of SCARs. However, the exact risk depends on several factors, including the patient's individual characteristics and medical history.
How can I reduce my risk of SCARs?
Patient can reduce their risk of SCARs by taking preventive measures, such as monitoring their skin for signs of SCARs and seeking medical attention immediately if they experience any symptoms. Patient should also follow their doctor's instructions for taking CBZ or ALLO, and attend all scheduled follow-up appointments.
What are the signs and symptoms of SCARs?
The signs and symptoms of SCARs include severe skin damage, blisters, ulcers, and skin detachment. Patient may also experience fever, fatigue, and muscle weakness. If patient experience any of these symptoms, they should seek medical attention immediately.
How is SCARs diagnosed?
SCARs is diagnosed based on a combination of clinical evaluation, laboratory tests, and medical history. The diagnosis is typically made by a doctor, who will perform a physical examination, take a medical history, and order laboratory tests to confirm the diagnosis.
What is the treatment for SCARs?
The treatment for SCARs typically involves stopping the medication that caused the reaction, and providing supportive care, such as wound care and pain management. In some cases, patient may need to be hospitalized to receive treatment.
More on: SCAR risk prediction Last reviewed: August 2, 2026

Community Disclaimer

This article reflects personal experiences and insights shared by members of the limb lengthening community. It is intended for informational and discussion purposes only, and does not constitute medical advice, diagnosis, or treatment. Individual experiences may vary. Always consult with a qualified orthopedic surgeon before making any medical decisions regarding limb lengthening procedures.

Explore Related Research

Clinical Insight

Limb Lengthening Risks

OverviewLimb lengthening, also known as distraction osteogenesis, is a surgical procedure that enables patients to increase the length of their bones. This procedure is often used to treat conditions such as limb length discrepancy or to repair damaged bones. According to a recent study published on PubMed, specific callus patterns in the intermediate stage of DO can have a negative impact on the consolidation of new bone tissue (Source: PubMed). This study highlights the importance of monitoring callus patterns during the DO process to ensure the best possible outcomes for patients.The study examined the outcomes of 129 patients who underwent lower limb DO and found that certain callus patterns were associated with delayed healing. Specifically, the presence of type 5/8 callus patterns was linked to longer distraction-consolidation times and higher healing indices. These findings have significant implications for patients undergoing DO, particularly those in older age groups or with longer distraction lengths.What This Study ExaminedThis study investigated the relationship between specific callus patterns and the outcomes of DO in a group of patients who underwent lower limb lengthening. The researchers reviewed the radiographic images of the patients and classified the callus patterns into different types, including type 5/8 callus patterns. They also analyzed the distraction-consolidation times and healing indices of the patients to determine the impact of the different callus patterns on the outcomes of DO.Why This Matters for PatientsUnderstanding the relationship between callus patterns and the outcomes of DO is crucial for patients who are considering undergoing this procedure. By recognizing the importance of monitoring callus patterns during the DO process, patients can work with their surgeons to optimize their treatment plan and minimize the risk of complications. This study provides valuable insights into the factors that can influence the success of DO and highlights the need for careful monitoring and management of callus patterns during the DO process.Medical BackgroundDO is a surgical procedure that involves the use of an external fixator or an intramedullary nail to gradually lengthen a bone. The procedure involves an osteotomy, or cut, in the bone, followed by the gradual distraction, or lengthening, of the bone using the external fixator or intramedullary nail. As the bone lengthens, new bone tissue forms in the gap, a process known as callotasis or bone regeneration.How the Procedure WorksThe DO procedure involves several stages, including the osteotomy, distraction, and consolidation phases. During the osteotomy phase, the surgeon makes a cut in the bone to create a gap. The distraction phase involves the gradual lengthening of the bone using the external fixator or intramedullary nail. The consolidation phase is the final stage, during which the new bone tissue forms and matures.Who Is a Candidate?DO is typically used to treat patients with limb length discrepancy or other conditions that require bone lengthening. The procedure can be used to treat both children and adults, although the specific indications and techniques may vary depending on the patient's age and condition.Clinical SummaryProcedure: Distraction osteogenesis (DO)Typical Duration: Several months to several yearsRecovery: Variable, depending on the patient's condition and the complexity of the procedureSuccess Rate (general): High, although complications can occurStudy MethodologyThe study was a retrospective cohort study that included 129 patients who underwent lower limb DO between 2003 and 2023. The patients had a mean age of 37.3 years and a mean distraction length of 53.2 mm. The researchers reviewed the radiographic images of the patients and classified the callus patterns into different types, including type 5/8 callus patterns.Patient Selection CriteriaThe patients included in the study underwent lower limb DO for a variety of indications, including limb length discrepancy and other conditions requiring bone lengthening. The patients were selected based on their availability for follow-up and the completeness of their radiographic records.Outcome MeasuresThe researchers analyzed several outcome measures, including distraction-consolidation time and healing index. They also evaluated the callus patterns of the patients and their relationship to the outcomes of DO.Results & FindingsThe study found that the presence of type 5/8 callus patterns was associated with longer distraction-consolidation times and higher healing indices. The researchers also found that the callus patterns were related to the age of the patients, with older patients having more delayed consolidation. Additionally, the study found that longer distraction lengths were associated with more delayed consolidation.Key OutcomesThe key outcomes of the study included the finding that type 5/8 callus patterns were associated with longer distraction-consolidation times and higher healing indices. The study also found that older patients and those with longer distraction lengths were at higher risk for delayed consolidation.Complications & RisksThe study found that the presence of type 5/8 callus patterns was associated with a higher risk of complications, including delayed consolidation and nonunion. The researchers also noted that older patients and those with longer distraction lengths were at higher risk for complications.Key Takeaways for PatientsPatient age and distraction length can impact the outcomes of DOType 5/8 callus patterns are associated with longer distraction-consolidation times and higher healing indicesMonitoring callus patterns during the DO process is crucial to optimize treatment outcomesPatients should discuss their individual risk factors with their surgeon to determine the best course of treatmentPrior to undergoing DO, patients should ask their surgeon about their individual risk factors and the potential complications associated with the procedure. Patients should also ask about the callus patterns that will be monitored during the DO process and how these patterns may impact their treatment outcomes.Frequently Asked QuestionsWhat is DO?DO is a surgical procedure that involves the use of an external fixator or an intramedullary nail to gradually lengthen a bone. The procedure is often used to treat conditions such as limb length discrepancy or to repair damaged bones.What are the risks associated with DO?The risks associated with DO include delayed consolidation, nonunion, and other complications. The presence of type 5/8 callus patterns has been associated with a higher risk of complications.How long does the DO process take?The DO process can take several months to several years, depending on the patient's condition and the complexity of the procedure.What is the success rate of DO?The success rate of DO is generally high, although complications can occur. The success rate can depend on various factors, including the patient's age, distraction length, and the presence of type 5/8 callus patterns.How can I optimize my treatment outcomes during the DO process?Patient age and distraction length can impact the outcomes of DO. Monitoring callus patterns during the DO process is crucial to optimize treatment outcomes. Patients should discuss their individual risk factors with their surgeon to determine the best course of treatment. Related Articles A Comprehensive Guide to Humeral Lengthening in Achondroplasia: Patient Perspectives and Treatment Outcomes Revolutionizing Achondroplasia Treatment: Understanding Vosoritide Therapy A Comprehensive Guide to Limb Lengthening in Achondroplasia: Understanding the Costs, Benefits, and Risks The Impact of Type 1 Diabetes Mellitus on Growth Patterns in Saudi Children and Adolescents: A Comprehensive Guide

Read Full Summary →
Clinical Insight

A Comprehensive Guide to Limb Lengthening in Achondroplasia: Understanding the Costs, Benefits, and Risks

Overview Achondroplasia is a genetic disorder that affects bone growth, leading to short stature and a range of other physical and emotional challenges. Limb lengthening surgery has emerged as a viable treatment option for individuals with achondroplasia, offering the potential to increase stature and improve overall quality of life. A recent study examined the cost-effectiveness of limb lengthening in patients with 1, using a Markov model to evaluate the economic impact of the procedure on the Spanish health system. This guide will delve into the medical background of achondroplasia and limb lengthening, explain the key takeaways from the study, and provide an in-depth look at the methodology, results, and potential complications of the procedure. Medical Background Achondroplasia is the most common form of short-limbed dwarfism, affecting approximately 1 in 25,000 to 1 in 30,000 births. The condition is caused by a mutation in the FGFR3 gene, which disrupts the normal process of bone growth and development. As a result, individuals with achondroplasia often experience a range of physical challenges, including short stature, bowed legs, and joint problems. Limb lengthening surgery, also known as distraction osteogenesis, is a procedure that involves cutting and gradually lengthening the bones of the legs or arms to increase stature. The procedure typically involves the use of an external fixator, a device that is attached to the bone and slowly lengthens it over time. The process of bone lengthening is complex and requires careful monitoring and management to minimize the risk of complications. The medical term 'quality-adjusted life years' (QALYs) refers to a measure of the value of health outcomes, taking into account both the quality and quantity of life. In the context of limb lengthening surgery, QALYs are used to evaluate the effectiveness of the procedure in improving the overall health and well-being of patients with achondroplasia. The 'incremental cost-effectiveness ratio' (ICER) is a statistical measure that compares the cost of a treatment to its effectiveness, expressed in terms of QALYs gained. The ICER is an important tool for evaluating the cost-effectiveness of medical interventions and informing healthcare policy decisions. Key Takeaways The study found that patients with achondroplasia who undergo limb lengthening surgery gain an average of 5.954 QALYs more than unoperated patients. The mean incremental cost of the procedure is €49,480, resulting in an ICER of €8,310/QALY. The probabilistic sensitivity analysis (PSA) yielded a mean quality of life gain of 6.287 QALYs and a mean cost increase of €49,131, translating to an ICER of €7,814/QALY. Limb lengthening surgery in patients with achondroplasia can be considered a cost-effective intervention according to commonly accepted willingness-to-pay thresholds in Spain and other Western countries. Methodology The study employed a Markov model to evaluate the cost-effectiveness of limb lengthening surgery in patients with achondroplasia. The Markov model is a statistical tool used to simulate the progression of a disease or condition over time, taking into account various health states and transitions. In this study, the model was used to estimate the costs and health outcomes of limb lengthening surgery compared to no surgery. The model was populated with data from a range of sources, including clinical trials, observational studies, and expert opinion. The study also performed a probabilistic sensitivity analysis (PSA) to account for uncertainty in the model parameters and estimate the robustness of the results. Results & Complications The study found that limb lengthening surgery is a cost-effective intervention for patients with achondroplasia, resulting in significant gains in QALYs and improved quality of life. However, as with any surgical procedure, there are potential risks and complications associated with limb lengthening. These may include infection, nerve damage, and complications related to the use of the external fixator. Patients should be carefully evaluated and monitored before and after surgery to minimize the risk of complications and ensure the best possible outcomes. The study's findings are subject to certain limitations, including the use of a hypothetical cohort and the reliance on modeling assumptions. However, the results provide valuable insights into the cost-effectiveness of limb lengthening surgery and can inform healthcare policy decisions and clinical practice guidelines. Further research is needed to fully understand the long-term outcomes and cost-effectiveness of the procedure. FAQ What is achondroplasia, and how does it affect the body? Achondroplasia is a genetic disorder that affects bone growth, leading to short stature and a range of other physical challenges. It can cause bowed legs, joint problems, and other complications that can impact daily life and overall health. What is limb lengthening surgery, and how does it work? Limb lengthening surgery involves cutting and gradually lengthening the bones of the legs or arms to increase stature. The procedure typically involves the use of an external fixator, a device that is attached to the bone and slowly lengthens it over time. What are the potential benefits and risks of limb lengthening surgery? The potential benefits of limb lengthening surgery include significant gains in QALYs and improved quality of life. However, there are also potential risks and complications, including infection, nerve damage, and complications related to the use of the external fixator. How long does the limb lengthening process take, and what kind of follow-up care is required? The limb lengthening process typically takes several months to a year or more to complete, depending on the individual case and the extent of lengthening required. Patients will require regular follow-up care with their surgeon and other healthcare providers to monitor progress and address any complications that may arise.

Read Full Summary →